21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Composition and methods for treating allergic response
#12902Passenger conveyor handrail drive device
#12903Methods and Compositions for the Treatment of CNS-Related Conditions
#12904Antimicrobial and Anticoagulant Compositions and Methods
#12905Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide
#12906Dietary Methods and Compositions for Enhancing Metabolism and Reducing Reactive Oxygen Species
#12907PRE-MIXED, READY-TO-USE IV BOLUS NICARDIPINE COMPOSITIONS AND METHODS OF USE
#12908Bicyclic heteroaryl inhibitors of PDE4
#12909Macrocyclic inhibitors of hepatitis C virus
#12910Methods to Treat Pain Using an Alpha-2 Adrenergic Agonist and an Endothelin Antagonist
#12911ENDOTHELIN RECEPTOR ANTAGONISTS FOR EARLY STAGE IDIOPATHIC PULMONARY FIBROSIS
#12912Compositions containing pufa and/or uridine and methods of use thereof
#12913INHIBITORS OF BRUTON'S TYROSINE KINASE
#12914Therapeutic combinations comprising a long acting dihydropyridine calcium-channel blocker and a statin
#12915Therapeutic Combination Comprising an Aurora Kinase Inhibitor and Imatinib
#12916Compositions of CHK1 inhibitors and cyclodextrin
#12917Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject
#12918THERAPEUTIC CAUSING CONTRACTION OF MUCOSAL TISSUE, METHOD OF TREATING DISEASES RELATING TO MUCOSAL TISSUES, INJECTOR AND THERAPEUTIC SET
#12919Solid oral dosage form containing an enhancer
#12920Polymer controlled induced viscosity fiber system and uses thereof
#12921Oral Moisturizer for Alleviating Dry Mouth
#12922FUNCTIONAL FOOD COMPOSITION THAT IS RICH IN PHENOLIC COMPOUNDS AND USE OF SAID COMPOSITION
#12923APPETITE SUPPRESSANT AND COLON CLEANSING COMPOSITION
#12924Methods for treating acute acoustic trauma
#12925Sustained release glp-1 receptor modulators
#12926Dimeric Prolactin Receptor Ligands
#12927Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity
#12928COMBINATION THERAPY FOR MODULATION OF ACTIVITY AND DEVELOPMENT OF CELLS AND TISSUES
#12929COMPOSITIONS AND METHODS OF CONTROLLING AND ADMINISTERING REDOX SPECIFIC FORMS OF DRUGS, FOODS AND DIETARY SUPPLEMENTS
#12930Hypolipidemic composition and its use
#12931COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
#12932Compositions and methods for treating acne
#12933Smoking Cessation Treatment By Reducing Nicotine Cravings, Apetite Suppression, And Altering The Perceived Taste Of Tobacco Smoke
#12934Reverse vitamin K effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets
#12935OM vitamin formula
#12936COMPOSITIONS COMPRISING COCONUT OIL AND METHODS OF USE THEREOF
#12937Compositions containing high omega-3 and low saturated fatty acid levels
#12938Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
#12939Extended release oral dosage composition
#12940Tablets and Preparation Thereof
#12941STEP-DOWN ESTROGEN REGIMEN FOR WOMEN RECEIVING ESTROGEN THERAPY
#12942PIMETHIXENE DERIVATIVES FOR PROMOTING BONE GROWTH
#12943Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
#12944BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME
#12945Methods and compositions for inhibiting the growth of hematopoietic malignant cells
#12946Methods of wound care and treatment
#12947DRUG FOR INHIBITING,PREVENTING OR TREATMENT OF RHEUMATOID ARTHRITIS
#12948Disease treatment via developing non-syngeneic graft transplantation
#12949Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
#12950Agent for promoting the production of thioredoxin
#12951Horse feed and treatment methods
#12952Cladribine regimen for treating multiple sclerosis
#12953Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)
#12954Methods for making and compositions comprising fermentation products of cordyceps sinensis
#12955Fusion proteins and methods for modulation of immune response
#12956COMBINATIONS OF PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDKS AND GSK'S
#12957Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
#12958Compounds, formulations, and methods for ameliorating telangiectasis
#12959Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus
#12960Protein kinase targeted therapeutics
#12961Methods and compositions for treating mammalian nerve tissue injuries
#12962Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events
#12963USE OF DRONEDARONE FOR THE TREATMENT OF PATIENTS WITH ARRHYTHMIA AND HAVING AN INCREASE OF CREATININE LEVEL DUE TO DRONEDARONE ADMINISTRATION
#12964Synergistic compositions consisting essentially of combinations of active agents selected from oridonin, wogonin, and isoliquiritigenin for the prevention of neoplasia
#12965Cannabinoids for use in the treatment of neuropathic pain
#12966Pathotropic targeted gene delivery system for cancer and other disorders
#12967Combined telomerase inhibitor and gemcitabine for the treatment of cancer
#12968Use of a p38 kinase inhibitor for treating psychiatric disorders
#12969Fixed Combination Dosage Forms for the Treatment of Migraine
#12970ALPHA-2B ADRENERGIC RECEPTOR AGONIST AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR COMPOSITIONS FOR TREATING CHRONIC PAIN
#12971Amino heterocyclic linked pyrimidine derivatives
#129725-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-arylquinolin-2-ones, a Process for their Production and their Use as Anti-inflammatory Agents
#12973METHODS FOR REDUCING THE RISK OF AN ADVERSE DRUG INTERACTION IN A PATIENT SUFFERING FROM INSOMNIA
#12974Methods of treating cholesterol gallstone disease with ezetimibe
#12975Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis
#12976Taxane Compounds for Treating Eye Disease
#12977Method of treating vitamin B12 deficiency
#12978Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof
#12979Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof
#12980Carbohydrates mixture
#12981Treatment of Melanoma With Alpha Thymosin Peptides
#12982Sensotherapy
#12983PHOTOACTIVATABLE ANTIMICROBIAL AGENTS
#12984Herbal preparation for sleep apnea relief
#12985Composition and method for improving human concentration, memory and other cognitive brain
#12986Pharmaceutical composition
#12987Carrageenan based antimicrobial compositions
#12988COMBINATION OF A LANTHANUM COMPOUND AND BONE ENHANCING AGENT FOR THE TREATMENT OF BONE DISEASES
#12989USE OF A COMPOSITION FOR SKIN TREATMENT UNDER X-IRRADIATION
#12990COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
#12991Bone Morphogenetic Protein Compositions
#12992Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
#12993NIACIN AND NSAID COMBINATION THERAPY
#12994METHODS AND MATERIALS FOR TREATING ACNE
#12995Cancellous construct with support ring for repair of osteochondral defects
#12996METHOD TO CONTROL DENGUE VIRUSES IN HUMANS BY PICOLINIC ACID AND DERIVATIVES THEREOF
#12997Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
#12998Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside
#12999Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
#13000Therapy with CD4 binding peptides and radiation
#13001EPITHELIUM-IMPROVING AGENT
#13002Supplement formula to prevent and deter muscle trauma and method of using same
#13003Compound preparation for quickly reducing oxidative stress and preparation of the same
#13004Methods And Kits For The Treatment Inhibition, And Maintenance Of Gastrointestinal Disorders
#13005Composition for high-ORAC value dietary supplement
#13006Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system
#13007Methods and compositions of treating a family viral infection
#13008Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
#13009MODIFIED STAT1 TRANSGENE THAT CONFERS INTERFERON HYPERRESPONSIVENESS, METHODS AND USES THEREFOR
#13010Combinations for HCV Treatment
#13011Compounds and compositions for delivering active agents
#13012USE OF IL-22 FOR THE TREATMENT OF CONDITIONS OF METABOLIC DISORDERS
#13013METHODS AND COMPOSITIONS FOR TREATING POSTOPERATIVE PAIN COMPRISING NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
#13014Combine radiation therapy and chemotherapy for treating cancer
#13015System and Method for the Prevention of Bacterial and Fungal Infections Including Urinary Tract Infection (UTI) Using N-Halogenated Amino Acids
#13016Radiation sensitizer or anti-cancer chemotherapy sensitizer
#13017Methods for treating mild cognitive impairment and alzheimer's disease
#13018Compositions and methods for treating jellyfish stings
#13019Proanthocyanidins for the Treatment of Amyloid and Alpha-Synuclein Diseases
#13020Cancer treatment by combined inhibition of proteasome and telomerase activities
#13021METHOD OF TREATMENT USING EPROSARTAN
#13022PHARMACEUTICAL FORMULATION FOR PARENTERAL ADMINISTRATION
#13023TRANSORAL DOSAGE FORMS COMPRISING SUFENTANIL AND NALOXONE
#13024Extended release hydrocodone acetaminophen and related methods and uses thereof
#13025Acute Pain Medications Based on Fast Acting Diclofenac-Opioid Combinations
#13026Statin and omega-3 fatty acids for reduction of Apo-B levels
#13027CANCER TREATMENT METHOD
#13028Improving renal function with quercetin-containing compositions
#13029ANTICANCER USE OF CAFFEIC ACID AND ITS DERIVATIVES
#13030AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS
#13031COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES
#13032SOLID DOSAGE FORMULATIONS OF TELCAGEPANT POTASSIUM
#13033NOVEL METHOD
#13034CONCURRENT DRUGS
#13035TREATMENT OF UTERINE CANCER AND OVARIAN CANCER WITH A PARP INHIBITOR ALONE OR IN CONBINATION WITH ANTI-TUMOR AGENTS
#13036Compositions and methods for improving cardiovascular function
#13037Anticancer Treatments
#13038Vγ9Vδ2 T cell proliferation agent, method for producing activated Vγ9Vδ2 T cells, and uses thereof
#13039Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs
#13040Anticancer Methods Using Extracts of Anemarrhena asphodeloides Bunge
#13041Use of composition for manufacture of medicant and method for inhibiting formation of body fat
#13042METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN FOR NON-SMALL-CELL LUNG CANCER BASED ON BRCA1 EXPRESSION
#13043CHEWABLE PHARYNGEAL INFLAMMATION SYMPTOM RELIEF COMPOSITION
#13044BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS
#13045Novel acetysalicylic acid formulations
#13046COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISORDERS
#13047Treatment of disc degenerative disease
#13048Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer
#13049Predicting response to a HER inhibitor
#13050Methods of treatment using IL-16 antagonist peptides
#13051USE OF SOLUBLE CD160 TO SUPPRESS IMMUNITY
#13052Administration of (S)-roscovitine for protection against and/or treatment of neurological diseases
#13053Organic Compounds
#13054TREATMENT OF APLASTIC ANEMIA
#13055Methods of inhibiting the lowering of antihuman TNF-α antibody
#13056Methods and compositions for treating platelet-related disorders
#13057COMBINATION DRUG
#13058ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS
#13059METHODS OF DIAGNOSIS AND TREATMENT FOR METABOLIC DISORDERS
#13060Use of fenretinide or bioactive derivatives thereof and pharmaceutical compositions comprising the same
#13061MAPC therapeutics without adjunctive immunosuppressive treatment
#13062Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
#13063SUSTAINED REMISSION OF ATOPIC DERMATITIS
#13064METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS
#13065Mixture of iron and copper salts masking metallic taste
#13066ANTI-OXIDANT DIETARY COMPOSITION CONTAINING FRUITS AND VEGETABLES, METHOD FOR PREPARING THE SAME AND USE OF THE COMPOSITION
#13067ANTI-OXIDATIVE CONTENT MATERIAL USED IN DRINK AND FOOD MANUFACTURING METHOD
#13068ALCOHOL METABOLISM ENHANCER AND ALCOHOLIC BEVERAGE
#13069Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
#13070Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
#13071AGENT FOR SUPPRESSING DEVELOPMENT OF TOLERANCE TO NARCOTIC ANALGESICS
#13072Inhibitors of bruton's tyrosine kinase
#13073Dopamine-agonist combination therapy for improving sleep quality
#13074COMBINATION COMPRISING A MEK INHIBITOR AND AN AURORA KINASE INHIBITOR 188
#13075NON-IMIDAZOLE ARYLOXYALKYLAMINES
#13076Medicinal lipolysis of accumulation of fat
#13077COMPOSITIONS OF PHOSPHODIESTERASE TYPE IV INHIBITORS
#13078SEQUENTIAL SPRM/ PROGESTIN TREATMENT
#13079DUAL PROTECTION OF MEDICINAL- PHARMACEUTICAL PRODUCTS AND NEW TECHNIQUES FOR THEIR APPLICATION
#13080PHARMACEUTICAL COMPOSITIONS
#13081Meloxicam and glucosamine formulation and uses thereof
#13082GLYCINE BETAINE AND ITS USE
#13083HEPARAN SULFATE PROTEOGLYCAN COMPOSITION AND USE THEREOF
#13084COMBINATION THERAPY
#130854′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
#13086COMBINATION COMPRISING N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-(1,3,4-OXADIAZOL-2-YL)PHENYL) PYRIDINE-3-SULPHONAMIDE AND AN LHRH ANALOGUE AND/OR A BISPHOSPHONATE
#13087Small Compounds That Correct Protein Misfolding and Uses Thereof
#13088Linseed Extract Medicament for Application to the Eye
#13089Mucosal membrane healant and moisturizer
#13090COMPOSITIONS COMPRISING RHODIOLA ROSEA AND METHODS OF USE THEREOF
#13091COMPOSITION POSSESSING ANTIOXIDANT, IMMONOMODULATED, AND ANTITUMOROUS ACTION AND METHOD OF TREATING NEOPLASMS
#13092Composition for preventing and treating fatty liver
#13093COMBINATION METHODS OF TREATING CANCER
#13094Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
#13095Compositions and methods for treating digestive disorders
#13096Antimicrobial nanoemulsion compositions and methods
#13097SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME
#13098Method and Composition for the Treatment of Skin Conditions
#13099METHOD AND COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS
#13100Antimicrobial Composition
#13101COMPOSITION AND USE OF RAR ANTAGONISTS FOR PROMOTING CHONDROGENESIS
#13102VASCULAR RESTENOSIS PREVENTING AGENT AND IMPLANTABLE INTRAVASCULAR DEVICE COATED THEREWITH
#13103Controlled Release Complex Formulation For Oral Administration of Medicine For Diabetes and Method For The Preparation Thereof
#13104Systems and methods for delivery of a therapeutic agent
#13105Methods for treating anthrax and inhibiting lethal factor
#13106FERMENTED COMPOSTIONS HAVING IMMUNODULATORY ACTIONS
#13107BLOCKING IMMUNE RESPONSE TO A GRAFT
#13108Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
#13109Combination Therapy
#13110Methods for bone regeneration using endothelial progenitor cell preparations
#131114′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
#13112External skin agent comprising modified clay for preventing inflammation
#13113Antimicrobial Topical and Other Preparations Containing Fluorescent or Illumination Dye and Tracer Agents or Compounds
#13114TREATMENT OF BREAST CANCER WITH A PARP INHIBITOR ALONE OR IN COMBINATION WITH ANTI-TUMOR AGENTS
#13115Transdermal Delivery Apparatus and Method
#13116Stimulation of cartilage formation using reduced pressure treatment
#13117Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
#13118Synthetic triterpenoids and methods of use in the treatment of disease
#13119NOVEL ACTIVES AGAINST PROSTATE CARCINOMA
#13120Medicinal Agent For Treating Viral Infections
#13121PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS
#131223,4-BICYCLIC PYRROLIDINE ANTIVIRALS
#13123RESVERATROL FORMULATIONS AND METHODS OF USE
#13124CANCER COMBINATION THERAPY COMPRISING AZD2171 AND IMATINIB
#13125Methotrexate adjuvants to reduce toxicity and methods for using the same
#13126VETERINARY PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND INFLAMMATION
#13127CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#13128Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy
#13129Treatment of pain using satraplatin
#13130Compositions and methods for tranquilizing heart muscle
#13131Methods and compositions for therapeutic treatment
#13132SKIN MATERIAL FOR EXTERNAL USE AND ANTIPRUTIRIC AGENT FOR EXTERNAL USE AND WRINKLE-INSTRUMENT USING THE SAME
#13133Designer therapy of pancreatic tumors
#13134Methods of treating an inflammatory-related disease
#13135Doxorubicin adjuvants to reduce toxicity and methods for using the same
#13136Cartilage regeneration-promoting agent
#13137Peptides having a health benefit and compositions comprising them
#13138Composition for acceleration of type I collagen production
#13139Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
#13140ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY
#13141Combination Product of Receptor Tyrosine Kinase Inhibitor and Fatty Acid Synthase Inhibitor for Treating Cancer
#13142Materials and methods for FOXP3 tumor suppression
#13143Composition Designed For The Treatment Of Multiple Sclerosis
#13144IMMUNE ENHANCEMENT BY SEED OIL AND/OR SEED FLOUR
#13145Plant extract mixtures and their uses
#13146Method for the production of a plant-based medicament
#13147Product and composition for alleviating post-menstrual symptoms
#13148Chinese herb extract for treating dementia and preparation method thereof
#13149TRAUMA THERAPY
#13150COMPOSITIONS AND METHODS FOR NUTRITION SUPPLEMENTATION
#13151Effective Antitumor Treatments
#13152NOVEL NASAL SPRAY
#13153METHODS OF TREATING BOWEL DISEASES BY ADMINISTERING A BOWEL CLEANSER AND AN ANTIBIOTIC
#13154THROAT CARE COMPOSITION
#13155METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME
#13156Use of solid carrier particles to improve the processability of a pharmaceutical agent
#13157HIGH DOSE ORAL PHARMACEUTICAL COMPOSITIONS OF ARTEMETHER AND LUMEFANTRINE
#13158METHODS AND COMPOSITIONS RELATED TO PRODUCTION OF COENZYME Q10
#13159PHYTONUTRIENT COMPOSITIONS FOR TOPICAL USE
#13160COMPOSITIONS CONTAINING (S)-BETHANECHOL AND THEIR USE IN THE TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES, GLUCOSE INTOLERANCE AND RELATED DISORDERS
#13161METHODS AND COMPOSITIONS FOR THE INHIBITION OF CATHEPSINS
#13162Transdermal hormone delivery system: compositions and methods
#13163Methods and kits for treating joints and soft tissues
#13164Osteogenic enhancer composition
#13165SPRAY-ON, NON-WOVEN FABRIC SYSTEM AND MULTILAYER TOPICAL COVERING
#13166Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use
#13167FISH OIL IN STABILIZED FORM
#13168METHOD OF TREATING AUTOIMMUNE DISEASE WITH MESENCHYMAL STEM CELLS
#13169Therapeutic Transplantation Using Developing, Human or Porcine, Renal or Hepatic, Grafts
#13170Cancer Therapies and Pharmaceutical Compositions Used Therein
#13171Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
#13172Composition and method to treat wounds
#131736-11 Bicyclic Ketolide Derivatives
#13174Methods and compositions for the treatment of symptoms of Williams Syndrome
#13175Transdiscal administration of cycline compounds
#13176Probiotic Oral Health Promoting Product
#13177SUBSTITUTED CYCLIC PYRROLIDINE DERIVATIVES
#13178SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
#13179Prophylactic or therapeutic agent for viral disease
#13180Compounds and compositions for delivering active agents
#13181Cancer treatment combining lymphodepleting agent with CTLs and cytokines
#13182Novel Compositions Against Alkyl-Acyul-GPC The Derivatitves and Products Thereof
#13183DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES
#13184Non-Covalent Inhibitors of AmpC ß-Lactamase
#13185LYCOPENE FOR THE TREATMENT OF METABOLIC DYSFUNCTION
#13186Novel Compositions for the Enhancement of the Anti-oxidant Potential of Hydrogenated Curcuminoids or Combinations Thereof
#13187Use of docosahexaenoic glycerides for the treatment of tumorous diseases
#13188METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DISORDERS
#13189PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS
#13190Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
#13191Therapy for the treatment of disease
#13192USE OF ISOINDOLES FOR THE TREATMENT OF NEUROBEHAVIORAL DISORDERS
#13193Aporphine derivatives and pharmaceutical use thereof
#13194Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same
#13195Method for treating cancer harboring EGFR mutations
#13196Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor
#13197Mono and Combination Therapy with M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Prodromal Syndrome
#13198ANTIBIOTIC COMPOSITION
#13199ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION
#13200Combination of azelastine and ciclesonide for nasal administration